IL140938A0 - Molecules designated b7l-1 - Google Patents

Molecules designated b7l-1

Info

Publication number
IL140938A0
IL140938A0 IL14093899A IL14093899A IL140938A0 IL 140938 A0 IL140938 A0 IL 140938A0 IL 14093899 A IL14093899 A IL 14093899A IL 14093899 A IL14093899 A IL 14093899A IL 140938 A0 IL140938 A0 IL 140938A0
Authority
IL
Israel
Prior art keywords
molecules designated
molecules
designated
polypeptides
purified
Prior art date
Application number
IL14093899A
Other languages
English (en)
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of IL140938A0 publication Critical patent/IL140938A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14093899A 1998-08-07 1999-08-05 Molecules designated b7l-1 IL140938A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9566398P 1998-08-07 1998-08-07
PCT/US1999/017906 WO2000008057A2 (en) 1998-08-07 1999-08-05 Molecules designated b7l-1

Publications (1)

Publication Number Publication Date
IL140938A0 true IL140938A0 (en) 2002-02-10

Family

ID=22253041

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14093899A IL140938A0 (en) 1998-08-07 1999-08-05 Molecules designated b7l-1
IL140938A IL140938A (en) 1998-08-07 2001-01-17 Dna sequences encoding polypeptides capable of binding to ldcam, polypeptides encoded by them, fusion proteins comprising the polypeptides and a process for the preparation of the polypeptides
IL196509A IL196509A (en) 1998-08-07 2009-01-14 Antibodies directed against polypeptides capable of binding to ldcam and pharmaceutical compositions comprising the same

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL140938A IL140938A (en) 1998-08-07 2001-01-17 Dna sequences encoding polypeptides capable of binding to ldcam, polypeptides encoded by them, fusion proteins comprising the polypeptides and a process for the preparation of the polypeptides
IL196509A IL196509A (en) 1998-08-07 2009-01-14 Antibodies directed against polypeptides capable of binding to ldcam and pharmaceutical compositions comprising the same

Country Status (10)

Country Link
US (3) US6512095B2 (de)
EP (1) EP1108042B1 (de)
AT (1) ATE415480T1 (de)
AU (1) AU771640B2 (de)
CA (1) CA2337712A1 (de)
DE (1) DE69939982D1 (de)
ES (1) ES2315016T3 (de)
IL (3) IL140938A0 (de)
NZ (1) NZ510357A (de)
WO (1) WO2000008057A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008057A2 (en) * 1998-08-07 2000-02-17 Immunex Corporation Molecules designated b7l-1
ATE484587T1 (de) * 1998-08-07 2010-10-15 Immunex Corp Ldcam genannte moleküle
US20030144478A1 (en) * 2001-02-06 2003-07-31 Immunex Corporation Molecules designated B7L-1
AU2588000A (en) * 1998-12-02 2000-06-19 Icos Corporation Novel adhesion molecule and methods of use
EP1067182A3 (de) * 1999-07-08 2001-11-21 Helix Research Institute Sekretorische- oder Membranproteine
US7129338B1 (en) * 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
WO2001029083A1 (en) * 1999-10-18 2001-04-26 Texas Biotechnology Corporation POLYNUCLEOTIDES ENCODING HUMAN AND MURINE ADHESION PROTEINS (BIgR)
JP2004500863A (ja) 2000-06-06 2004-01-15 ブリストル−マイヤーズ　スクイブ　カンパニー 免疫調節に有用なｂ７関連核酸およびポリペプチド
JP2004501625A (ja) * 2000-06-28 2004-01-22 アムジェン　インコーポレーテッド Ｂ７様分子およびその使用
ZA200508985B (en) * 2001-07-10 2006-07-26 Biogen Idec Inc Inhibition of apotosis process and improvement of cell performance
JP2003116561A (ja) * 2001-10-11 2003-04-22 National Cancer Center-Japan Ｔｓｌｌ１遺伝子
US20040053307A1 (en) * 2002-06-17 2004-03-18 Wyeth Inhibition of T cell activation by butyrophilin 4 and B7-L1
EP2133362B1 (de) * 2003-07-25 2012-04-18 Amgen, Inc Verfahren bezüglich LDCAM und CRTAM
WO2007109370A2 (en) 2006-03-22 2007-09-27 Viral Logic Systems Technology Corp. Methods for identifying polypeptide targets and uses thereof for treating immunological diseases
EP2069793B9 (de) * 2006-08-29 2017-08-16 Oxford BioTherapeutics Ltd Identifizierung von mit hepatozellulärem karzinom, glioblastom und lungenkrebs assoziiertem protein
ES2639026T3 (es) 2009-03-05 2017-10-25 Oxford Biotherapeutics Ltd. Anticuerpos totalmente humanos específicos para CADM1
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9708375B2 (en) 2013-03-15 2017-07-18 Amgen Inc. Inhibitory polypeptides specific to WNT inhibitors
US11802226B2 (en) * 2013-07-30 2023-10-31 H.B. Fuller Company Polyurethane adhesive film
US11427627B2 (en) 2013-09-05 2022-08-30 Amgen Inc. Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
CA2949237C (en) 2014-05-16 2022-08-23 Amgen Inc. Assay for detecting th1 and th2 cell populations
MA47775A (fr) 2017-03-14 2020-01-22 Amgen Inc Contrôle des glycoformes afucosylées totales d'anticorps produits en culture cellulaire
IL313983A (en) 2018-03-26 2024-08-01 Amgen Inc Fully fucose-free glycoforms of antibodies are produced in cell culture
CA3152547A1 (en) 2019-09-26 2021-04-01 Amgen Inc. Methods of producing antibody compositions
US20230273126A1 (en) 2020-06-04 2023-08-31 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
EP4229080A1 (de) 2020-10-15 2023-08-23 Amgen Inc. Relative ungepaarte glycane in antikörperherstellungsverfahren
AR126089A1 (es) 2021-06-07 2023-09-13 Amgen Inc Uso de fucosidasa para controlar el nivel de afucosilación de proteínas glucosiladas
CA3233279A1 (en) 2021-10-05 2023-04-13 Amgen Inc. Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218510B1 (en) 1994-03-02 2001-04-17 Brigham & Woman's Hospital B7-1 and B7-2 polypeptides
WO1998054963A2 (en) 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins
WO1998044113A1 (en) * 1997-03-28 1998-10-08 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2285447A1 (en) 1997-03-28 1998-10-08 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
NZ503343A (en) 1997-09-17 2002-09-27 Genentech Inc Secreted and transmembrane polypeptides and use to induce apoptosis of tumour cells
EP0939124A3 (de) 1998-02-24 2001-03-21 Smithkline Beecham Plc MBGP1-Sequenzen
WO2000008057A2 (en) 1998-08-07 2000-02-17 Immunex Corporation Molecules designated b7l-1
AU2588000A (en) 1998-12-02 2000-06-19 Icos Corporation Novel adhesion molecule and methods of use
AU2600800A (en) 1999-03-08 2000-09-28 Genentech Inc. Promotion or inhibition of angiogenesis and cardiovascularization
CN1242376A (zh) 1999-07-27 2000-01-26 中国医学科学院基础医学研究所 人神经系统特异表达基因

Also Published As

Publication number Publication date
IL196509A (en) 2011-04-28
ATE415480T1 (de) 2008-12-15
AU5550499A (en) 2000-02-28
ES2315016T3 (es) 2009-03-16
US20080075724A1 (en) 2008-03-27
IL140938A (en) 2010-12-30
WO2000008057A2 (en) 2000-02-17
EP1108042A2 (de) 2001-06-20
US6512095B2 (en) 2003-01-28
IL196509A0 (en) 2009-09-22
US7939640B2 (en) 2011-05-10
NZ510357A (en) 2004-02-27
WO2000008057A3 (en) 2000-05-18
AU771640B2 (en) 2004-04-01
US20100168399A1 (en) 2010-07-01
DE69939982D1 (de) 2009-01-08
CA2337712A1 (en) 2000-02-17
EP1108042B1 (de) 2008-11-26
US20020164686A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
NZ510357A (en) Molecules designated B7L-1
IL140937A0 (en) Molecules designated ldcam
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
IL193919A0 (en) DcR3 POLYPEPTIDE A TNFR HOMOLOG
HK1040401A1 (en) Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof
HK1013847A1 (en) Gdf-1 and uog-1 proteins
EP0712862A3 (de) Selektive Acylierung von Epsilon-Aminogruppen
ES2145015T3 (es) Proteasas especificas de ubiquitina.
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
AU3802595A (en) Tripeptidyl aminopeptidase
MX9702341A (es) Citoquina designada lerk-6.
NZ294019A (en) Proteins associated with the hippocampus; dna sequences coding therefor, antibodies to the proteins
DE69939587D1 (en) Semaphorin polypeptide
AU3118095A (en) Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
AU4046599A (en) Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof
ZA99445B (en) Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof.
TW342413B (en) Novel toxins isolated from Bracon Hebetor
IE882662L (en) Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins